Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-25 @ 4:59 AM
NCT ID:
NCT00526318
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of neuroblastoma according to any of the following criteria:
* Histological diagnosis from tumor tissue
* Presence of distinct neuroblastoma cells in the bone marrow and elevated catecholamine metabolites (HVA, VMA) in blood or urine
* High-risk disease, meeting 1 of the following criteria:
* Stage 4 disease, regardless of the MYCN status (1-21 years of age)
* Stage 1-3 or 4S disease with MYCN amplification (6 months -21 years of age)
PATIENT CHARACTERISTICS:
* Not pregnant or nursing
* Fertile patients must use effective contraception (hormonal contraception or intra-uterine device \[IUD\])
PRIOR CONCURRENT THERAPY:
* No concurrent participation in another clinical trial that would preclude the interventions or outcome assessment of this clinical trial
* No other concurrent anticancer therapy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT00526318
Study Brief:
Protocol Section:
NCT00526318